Sponsor
University of Zurich
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name University of Zurich appears in 277 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownFeasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate CancerNCT07042256 · lead sponsor · 2026-06-09
RECRUITINGAuditory Sleep Stimulation or Sham in People With Parkinson Disease Mild Cognitive Impairment During Cognitive TrainingNCT07441915 · lead sponsor · 2026-04-22
RECRUITINGNatural Cervical Ripening to Prevent Pharmacological Induction of Labor - a Pilot Study.NCT07587632 · lead sponsor · 2026-04-10
RECRUITINGRole of Slow Waves in the Progression of Neurodegeneration in Isolated REM Sleep Behavior DisorderNCT07355842 · lead sponsor · 2026-01-15
RECRUITINGSafety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without AsthmaNCT06960382 · lead sponsor · 2025-08-20
RECRUITINGMR-informed Stereotactic Radiotherapy for Treatment of Ultracentral Lung Tumours Utilising a Dedicated MR-simulator for Daily Adaptation Followed by CBCT-guided Treatment DeliveryNCT06815289 · lead sponsor · 2025-07-31
RECRUITINGPersonalized Stimulation Loop for Neurorehabilitation in Parkinson: a Proof-of-principle StudyNCT07082595 · lead sponsor · 2025-07-07
RECRUITINGVisa-versa! Breaking Instead of Pushing the Pedals-CNCT05204693 · lead sponsor · 2025-06-01
RECRUITINGUltrasound-guided Cryobiopsy of Mediastinal/Hilar Lymph NodesNCT06921681 · lead sponsor · 2025-03-07
RECRUITINGMolecular Underpinnings of Heart Failure, Integrative Multi-Omics, and Non-Coding RNA ProfilingNCT07158086 · lead sponsor · 2025-02-01
RECRUITINGImaging Quality and Potential Clinical Relevance of Phase Contrast Mammography In-vivo: a Single-center, Prospective StudyNCT06489665 · lead sponsor · 2024-10-17
RECRUITINGLongitudinal Monitoring During Intermittent Fasting Protocols in Obese AdultsNCT06323889 · lead sponsor · 2024-09-23
RECRUITINGBreath Analysis for the Detection of Invasive Fungal InfectionsNCT06537726 · lead sponsor · 2024-08-19
RECRUITINGPrecision Sensorimotor Neurorehabilitation Through Personalized Stimulation LoopsNCT06608875 · lead sponsor · 2024-05-16
RECRUITINGOnline Adaptive Stereotactic Body Radiotherapy for Localized Prostate CancerNCT06834152 · lead sponsor · 2024-03-01
RECRUITINGDirect Measurement of Ingestive Behaviour in Relation to Sex Differences and Gastrointestinal Hormone Levels in Patients After Metabolic and Bariatric SurgeryNCT06538948 · lead sponsor · 2024-02-13
RECRUITINGUltra Low Dose CT and Use of Iomeron 400 in PCD-CTNCT06360627 · lead sponsor · 2023-02-20
RECRUITINGThe Acute Cardiorespiratory Response to Blood-flow Restricted Versus Traditional Exercise Training Regimens (CaRe BFR)NCT05163600 · lead sponsor · 2022-05-20
RECRUITINGThe SwissPrEPared StudyNCT03893188 · lead sponsor · 2019-04-10
RECRUITINGPulmonary Hypertension Registry SwitzerlandNCT05610631 · lead sponsor · 2017-06-01
RECRUITINGProspective Longitudinal Observational Research in Atopic DermatitisNCT04240522 · lead sponsor · 2017-04-04
RECRUITINGCharacterization of Acute and Recent HIV-1 Infections in Zurich.NCT00537966 · lead sponsor · 2002-01-01
RECRUITINGWeekly Online CT or MR Adaptive Definitive SBRT for Regionally Metastatic Prostate CancerNCT07591051 · lead sponsor · 2027-01-01
NOT_YET_RECRUITINGFasting, Exercise, and Diet to Activate Autophagy in DepressionNCT07664540 · lead sponsor · 2026-09-11
NOT_YET_RECRUITINGScreening for Brain MetastasesNCT07492121 · lead sponsor · 2026-09-01
NOT_YET_RECRUITINGEvaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, SwitzerlandNCT07516912 · lead sponsor · 2026-04-07
NOT_YET_RECRUITINGEffects of Fecal Microbiota Transplantation in Patients With Type 2 Diabetes and Coronary Artery Disease (CAD-Microbiome) - A Pilot StudyNCT07421947 · lead sponsor · 2026-04-01
NOT_YET_RECRUITINGEmotional-distress-based Integrated Care Programme in Patients With Stable COPDNCT07524023 · lead sponsor · 2026-03-16
ACTIVE_NOT_RECRUITINGEmotional-distress-based Integrated Care Programme in Patients With an Acute Exacerbation of COPDNCT07351929 · lead sponsor · 2026-01-12
ACTIVE_NOT_RECRUITINGDoes Anesthesia Technique Impact on the Long-term Outcome 5 and 10 Years After the First Intervention in Primary Breast Cancer Surgery? A Follow-up Analysis.NCT07689253 · lead sponsor · 2025-09-01
COMPLETEDRENEW-SHCS: Safety and Immunogenicity of a Recombinant HIV Env Protein Vaccine in ARV-treated Adults Living With HIV in the SHCSNCT07769983 · lead sponsor · 2025-02-25
ENROLLING_BY_INVITATIONAdaptive MR-guided SBRT for Localized Prostate CancerNCT04571762 · lead sponsor · 2024-09-30
UNKNOWNEarly Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen ResponseNCT06822491 · lead sponsor · 2024-08-20
ACTIVE_NOT_RECRUITINGHigh Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m)NCT06489704 · lead sponsor · 2024-07-02
COMPLETEDHigh Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), 6MWT Assessed at High Altitude (3200m) vs Low Altitude (760m)NCT06489691 · lead sponsor · 2024-07-02
COMPLETEDHigh Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), SDB Assessed at HA (3200 m) vs LA (760 m)NCT06489717 · lead sponsor · 2024-07-02
COMPLETEDHAPH Registry: Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.NCT06489730 · lead sponsor · 2024-07-01
UNKNOWNHighlanders With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Arterial Pressure (PAP) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)NCT06489756 · lead sponsor · 2024-07-01
COMPLETEDHighlanders With High Altitude Pulmonary Hypertension (HAPH), 6 Minute Walk Distance (6MWD) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)NCT06489743 · lead sponsor · 2024-07-01
COMPLETEDBenefit of Cone-beam CT and Robotic-Assisted Bronchoscopy During BronchoscopyNCT06489678 · lead sponsor · 2024-06-25
ACTIVE_NOT_RECRUITINGWhole-body Hyperthermia for DepressionNCT06323785 · lead sponsor · 2024-06-15
UNKNOWNExercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy in Pulmonary Vascular Disease (PVD)NCT06384534 · lead sponsor · 2024-04-01
COMPLETEDValidity and Reliability of the 12-item Multiple Sclerosis Walking Scale (12-WS) in Subjects With Spinal Cord InjuryNCT06256159 · lead sponsor · 2024-03-22
COMPLETEDVisa-versa! Breaking Instead of Pushing the Pedals-BNCT05185856 · lead sponsor · 2023-11-15
COMPLETEDDoxycycline PEP and 4CMenB as a Comprehensive Prevention Strategy in MSM and TGW at High Risk for Bacterial STIs Within the Swiss HIV Cohort StudyNCT06242730 · lead sponsor · 2023-11-01
UNKNOWNHigh Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)NCT06003244 · lead sponsor · 2023-09-23
UNKNOWNHigh Altitude (HA) Residents With Pulmonary Vascular Diseseases (PVD), Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) vs Sea Level (LA)NCT06092424 · lead sponsor · 2023-09-23
UNKNOWNHA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)NCT06072417 · lead sponsor · 2023-09-22
UNKNOWNHA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level)NCT05996302 · lead sponsor · 2023-07-05
UNKNOWNHA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)NCT06084559 · lead sponsor · 2023-07-05
UNKNOWNValue of Ultra-fast Prostate MRI in Prostate CancerNCT05903781 · lead sponsor · 2023-06-26
COMPLETEDHolistic Wellbeing in COPD: Communication About Sexuality (COSY)NCT05696730 · lead sponsor · 2023-03-21
COMPLETEDIntrathecal Double Checkpoint InhibitionNCT05598853 · lead sponsor · 2022-11-25
ACTIVE_NOT_RECRUITINGExploring the Recovery Function of Sleep in NeurodegenerationNCT05402488 · lead sponsor · 2022-03-14
UNKNOWNCabotegravir Plus Rilpivirine Long-acting Regimen in the Swiss HIV Cohort Study:Uptake, Outcome, and Risk Factors for Treatment FailuresNCT06405464 · lead sponsor · 2022-03-01
UNKNOWNSensing Physical Activity to Evaluate and Monitor a Routine Aftercare Program (SensE-M)NCT05243407 · lead sponsor · 2022-02-21
COMPLETEDVisa-versa! Breaking Instead of Pushing the Pedals-ANCT05186987 · lead sponsor · 2022-02-15
COMPLETEDIntralymphatic Immunotherapy With Polvac Grass & Rye Allergen ExtractNCT05297760 · lead sponsor · 2022-02-10
COMPLETEDBCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection:NCT05004038 · lead sponsor · 2022-01-04
COMPLETEDThe SWISSHEART Failure Network (SHFN)NCT05603247 · lead sponsor · 2021-11-01
UNKNOWNSponsor roles
lead sponsor238
collaborator39
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.